Can Diffuse Large B-Cell Lymphoma Cause Pruritus?
Yes, diffuse large B-cell lymphoma (DLBCL) can cause pruritus, though it is uncommon compared to Hodgkin lymphoma, and when present, it should prompt immediate evaluation for systemic disease. 1
Epidemiology and Disease Association
- Pruritus is uncommon in most non-Hodgkin lymphoma subtypes, including DLBCL, distinguishing it from Hodgkin lymphoma where itch is a characteristic paraneoplastic feature. 1
- In contrast to Hodgkin lymphoma, where pruritus frequently appears weeks to months before other clinical signs, DLBCL-associated pruritus is not a typical presenting symptom. 1
- Haematological malignancies overall account for approximately 2% of all cases of generalized pruritus, making lymphoma a relatively rare but important cause to consider. 1
Clinical Presentation When Pruritus Occurs
When DLBCL does present with pruritus, specific red-flag features should be identified:
- Nocturnal itching accompanied by B symptoms (fever, night sweats, unintended weight loss) is highly suggestive of underlying lymphoma and requires immediate evaluation. 1
- Generalized pruritus without primary skin lesions or identifiable dermatosis raises suspicion for systemic causes including lymphoma. 1
- Palpable lymphadenopathy or soft-tissue masses on physical examination constitute key red-flag signs in patients with unexplained itch. 1
- DLBCL may present with pruritic erythematous plaques and nodules when there is extensive cutaneous infiltration, accompanied by constitutional symptoms and organomegaly. 2
Diagnostic Approach
Initial laboratory screening should include: 1
- Full blood count with peripheral blood film
- Lactate dehydrogenase (LDH)
- Erythrocyte sedimentation rate (ESR)
Tissue diagnosis is essential: 1
- Excisional lymph node biopsy or ultrasound-guided core biopsy for any clinically enlarged node
- Skin biopsy from the trunk may be considered when pruritus persists despite normal skin examination to exclude cutaneous lymphoma
Pathophysiology
- Lymphoma-related itch operates through non-histaminergic pathways, with elevated cytokines including IL-31, IL-1β, and IL-1α, explaining why conventional antihistamines are ineffective. 1
Treatment Recommendations
Definitive therapy:
- Curative treatment of the underlying DLBCL consistently resolves the associated pruritus, making disease-directed therapy the primary approach. 1
Symptomatic management during treatment: 3, 1
- High-dose oral corticosteroids provide rapid itch control and are recommended first-line for symptomatic relief
- Adjunctive agents with demonstrated benefit include:
- Cimetidine
- Gabapentin
- Carbamazepine
- Mirtazapine
- Narrowband UVB phototherapy may provide temporary relief for non-Hodgkin lymphoma-associated pruritus 3
In incurable disease:
- Oral corticosteroids remain the recommended first-line option for itch management. 1
Critical Clinical Pitfall
Traditional antihistamines are generally ineffective for lymphoma-related pruritus and should not be relied upon as monotherapy, as the itch is mediated through non-histaminergic pathways. 1 This is a common mistake that delays effective symptom control.